Loading…

Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA—A study protocol

Wide resection remains the cornerstone of localized soft-tissue sarcomas (STS) treatment. Neoadjuvant radiation therapy (NRT) may decrease the risk of local recurrences; however, its effectiveness for different histological STS subtypes has not been systematically investigated. The proposed prospect...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2023-11, Vol.18 (11), p.e0285580-e0285580
Main Authors: Runkel, Alexander, Braig, David, Bogner, Balazs, Schmid, Adrian, Lausch, Ute, Boneberg, Anika, Brugger, Zacharias, Eisenhardt, Anja, Kiefer, Jurij, Pauli, Thomas, Boerries, Melanie, Fuellgraf, Hannah, Kurowski, Konrad, Bronsert, Peter, Scholber, Jutta, Grosu, Anca-Ligia, Rovedo, Philipp, Bamberg, Fabian, Eisenhardt, Steffen Ulrich, Jung, Matthias
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Wide resection remains the cornerstone of localized soft-tissue sarcomas (STS) treatment. Neoadjuvant radiation therapy (NRT) may decrease the risk of local recurrences; however, its effectiveness for different histological STS subtypes has not been systematically investigated. The proposed prospective study evaluates the NRT response in STS using liquid biopsies and the correlation of multiparametric magnetic resonance imaging (mpMRI) with histopathology and immunohistochemistry. Liquid biopsies Preliminary data support the notion that quantification of ctDNA in combination with tumor mass characterization through co-registration of mpMRI and histopathology can predict NRT response of STS. The methods presented in this prospective study are necessary to assess therapy response in heterogeneous tumors and lay the foundation of future patient- and tumor-specific therapy concepts. These methods can be applied to various tumor entities. Thus, the participation and support of a wider group of oncologic surgeons are needed to validate these findings on a larger patient cohort.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0285580